Results for 'direct-to-consumer'

984 found
Order:
  1. Direct-to-Consumer Advertising of Pharmaceuticals as a Matter of Corporate Social Responsibility?Pepijn K. C. van de Pol & Frank G. A. de Bakker - 2010 - Journal of Business Ethics 94 (2):211-224.
    Direct-to-consumer advertising (DTCA) of prescription drugs has been a heavily contested issue over the past decade, touching on several issues of responsibility facing the pharmaceutical industry. Much research has been conducted on DTCA, but hardly any studies have discussed this topic from a corporate social responsibility (CSR) perspective. In this article, we use several elements of CSR, emphasising consumer autonomy and safety, to analyse differences in DTCA practices within two different policy contexts, the United States of America (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  2.  20
    Direct-to-consumer advertising effects on nurse–patient relationship, authority, and prescribing appropriateness.Anna A. Filipova - 2018 - Nursing Ethics 25 (7):823-840.
    Background: Discussing direct-to-consumer advertising of prescription drugs during a visit could affect prescribing practices and provider–patient relationship. Research objectives: The study examines advanced practice nurse prescribers’ perceptions of direct-to-consumer advertising and its effects on nurse–patient relationship, prescriptive authority, and appropriateness of patient clinical requests. Research design: A cross-sectional survey design was implemented. Participants and research context: The random sample consisted of 316 nurses (27.17% response rate) in one of the Midwestern states in the United States. Pearson’s (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  3.  14
    Direct to consumer testing in reproductive contexts – should health professionals be concerned?Heather Skirton - 2015 - Life Sciences, Society and Policy 11 (1):1-9.
    Direct to consumer genetic testing offered via the Internet has been available for over a decade. Initially most tests of this type were offered without the input of the consumer’s own health professional. Ethical and practical concerns have been a raised over the use of such tests: these include fulfilling the requirement for informed consent, utility of results for health care management and the potential burden placed upon health services by people who have taken tests.
    Direct download  
     
    Export citation  
     
    Bookmark   1 citation  
  4.  20
    Direct to Consumer Advertising in Health Care and Orthopedics: A Review and Ethical Considerations.Abhijit Manaswi & William M. Mihalko - 2010 - Ethics in Biology, Engineering and Medicine 1 (3):215-245.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  5.  47
    Direct-to-consumer advertisements for prescription drugs as an argumentative activity type.Renske Wierda & Jacky Visser - 2012 - Journal of Argumentation in Context 1 (1):81-96.
    With direct-to-consumer advertisements (DTCA), pharmaceutical companies can market their prescription drugs directly to consumers. In order to properly study the argumentative aspect of these advertisements from a pragma-dialectical perspective, it is necessary to characterize DTCA as an ‘argumentative activity type’. This characterization shows that in DTCA, the advertiser combines two genres of communicative activity: promotion and consultation. The use of promotion stems from the advertiser’s commercial objective of selling products, while the use of consultation is a result of (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  6. The ethical challenges of direct-to-consumer genetic testing.Cheryl Berg & Kelly Fryer-Edwards - 2008 - Journal of Business Ethics 77 (1):17 - 31.
    Genetic testing is currently subject to little oversight, despite the significant ethical issues involved. Repeated recommendations for increased regulation of the genetic testing market have led to little progress in the policy arena. A 2005 Internet search identified 13 websites offering health-related genetic testing for direct purchase by the consumer. Further examination of these sites showed that overall, biotech companies are not providing enough information for consumers to make well-informed decisions; they are not consistently offering genetic counseling services; (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   6 citations  
  7.  77
    Direct-to-Consumer Advertising: Should There Be a Free Market in Healthcare Information?Andreas Hasman & Søren Holm - 2006 - Cambridge Quarterly of Healthcare Ethics 15 (1):42-49.
    On June 3, 2003, the European Council of health ministers rejected a proposal from the European Commission to allow drug manufacturers to advertise directly to particular groups of patients; the proposal had already been rejected by the European Parliament subsequent to a heated public debate in which consumer and patient groups almost unanimously argued that it was not the role of drug companies to provide information to patients. The pilot scheme suggested by the Commission would only have applied to (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  8.  7
    Direct-to-Consumer Advertising of Pharmaceuticals as a Matter of Corporate Social Responsibility?Pepijn Pol & Frank Bakker - 2010 - Journal of Business Ethics 94 (2):211-224.
    Direct-to-consumer advertising (DTCA) of prescription drugs has been a heavily contested issue over the past decade, touching on several issues of responsibility facing the pharmaceutical industry. Much research has been conducted on DTCA, but hardly any studies have discussed this topic from a corporate social responsibility (CSR) perspective. In this article, we use several elements of CSR, emphasising consumer autonomy and safety, to analyse differences in DTCA practices within two different policy contexts, the United States of America (...)
    Direct download  
     
    Export citation  
     
    Bookmark   4 citations  
  9.  22
    US direct-to-consumer medical service advertisements fail to provide adequate information on quality and cost of care.Sung-Yeon Park, Gi Woong Yun, Sarah Friedman, Kylie Hill, So Young Ryu, Thomas L. Schwenk & Max J. Coppes - 2021 - Journal of Medical Ethics 47 (12):e52-e52.
    BackgroundIn the 1970s, the Federal Trade Commission declared that allowing medical providers to advertise directly to consumers would be “providing the public with truthful information about the price, quality or other aspects of their service.” However, our understanding of the advertising content is highly limited.ObjectiveTo assess whether direct-to-consumer medical service advertisements provide relevant information on access, quality and cost of care, a content analysis was conducted.MethodTelevision and online advertisements for medical services directly targeting consumers were collected in two (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  10.  35
    Direct to consumer genetic testing and the libertarian right to test.Wendy Elizabeth Bonython & Bruce Baer Arnold - 2018 - Journal of Medical Ethics 44 (11):787-789.
    Loi recently proposed a libertarian right to direct to consumer genetic testing — independent of autonomy or utility—reflecting Cohen’s work on self-ownership and Hohfeld’s model of jural relations. Cohen’s model of libertarianism dealt principally with self-ownership of the physical body. Although Loi adequately accounts for the physical properties of DNA, DNA is also an informational substrate, highly conserved within families. Information about the genome of relatives of the person undergoing testing may be extrapolated without requiring direct engagement (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  11.  10
    Direct to consumer genetic testing.Mwenza Blell & M. A. Diamond-Hunter - 2019 - Frontiers in Medicine 6 (48).
    The growth in the direct-to-consumer genetic testing industry poses a number of challenges for healthcare practice, among a number of other areas of concern. Several companies providing this service send their customers reports including information variously referred to as genetic ethnicity, genetic heritage, biogeographic ancestry, and genetic ancestry. In this article, we argue that such information should not be used in healthcare consultations or to assess health risks. Far from representing a move toward personalized medicine, use of this (...)
    Direct download  
     
    Export citation  
     
    Bookmark   1 citation  
  12.  26
    Direct-To-Consumer Genetics and Health Policy: A Worst-Case Scenario?Timothy Caulfield - 2009 - American Journal of Bioethics 9 (6-7):48-50.
    There is currently little evidence that the information provided by personal genomics companies—such as 23andMe and Navigenics—on a direct-to-consumer (DTC) basis, has any real health value. To be...
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  13.  32
    Direct-to-Consumer Genomics Companies Should Provide Guidance to Their Customers on (Not) Sharing Personal Genomic Information.Nanibaa’ A. Garrison & Amy L. Non - 2014 - American Journal of Bioethics 14 (11):55-57.
  14.  40
    Direct-to-Consumer Genomics, Social Networking, and Confidentiality.David B. Resnik - 2009 - American Journal of Bioethics 9 (6-7):45-46.
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  15. Direct-to-consumer genomics and personal health data.Jorge L. Contreras - 2021 - In I. Glenn Cohen, Nita A. Farahany, Henry T. Greely & Carmel Shachar (eds.), Consumer genetic technologies: ethical and legal considerations. New York, NY: Cambridge University Press.
     
    Export citation  
     
    Bookmark  
  16.  63
    Direct-to-Consumer Genetic Tests and the Right to Know.Ronni Sandroff - 2010 - Hastings Center Report 40 (5):24-25.
  17.  33
    Does Direct-to-Consumer Marketing of Medical Technologies Undermine the Physician–Patient Relationship?Leah Rosenberg - 2009 - American Journal of Bioethics 9 (4):22-23.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  18.  40
    Direct-to-Consumer Genetic Testing and Its Marketing: Emergent Ethical and Public Policy Implications.Alexander Nill & Gene Laczniak - 2020 - Journal of Business Ethics 175 (4):669-688.
    This paper provides a marketing ethics analysis that addresses the practice of selling genetic tests directly to the consumer. It details the complexity of this emergent sector by articulating the panoply of evolving ethical/social questions raised by this development. It advances the conversation about DTC genetic testing by reviewing the business and healthcare literature concerning this topic and by laying out the inherent ethical complications for consumers, marketers, and regulators. It also points to several possible public and company policy (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  19.  23
    Direct-to-Consumer Marketing of Dietary Supplements for Dementia: An Example of Unhealthy Commerce of Neuroscience.Nicole Palmour & Eric Racine - 2011 - American Journal of Bioethics Neuroscience 2 (4):30-33.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  20.  36
    Direct-to-Consumer Neurotechnologies and Quantified Relationship Technologies: Overlapping Ethical Concerns.Sven Nyholm, Brian D. Earp & John Danaher - 2019 - American Journal of Bioethics Neuroscience 10 (4):167-170.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  21. Direct to Consumer Personal Genomic Testing and Trust : A Comparative Focus Group Study of Lay Perspectives in Germany, Israel, the Netherlands and the UK.Aviad Raz Manuel Schaper, Karim Raza Marie Falahee, Elisa Garcia Gonzalez Danielle Timmermans & Sabine Wöhlke Silke Schicktanz - 2021 - In Ulrik Kihlbom, Mats G. Hansson & Silke Schicktanz (eds.), Ethical, social and psychological impacts of genomic risk communication. New York, NY: Routledge.
     
    Export citation  
     
    Bookmark  
  22.  38
    Ethical concerns with online direct-to-consumer pharmaceutical companies.Henry Curtis & Joseph Milner - 2020 - Journal of Medical Ethics 46 (3):168-171.
    In recent years, online direct-to-consumer pharmaceutical companies have been created as an alternative method for individuals to get prescription medications. While these companies have noble aims to provide easier, more cost-effective access to medication, the fact that these companies both issue prescriptions as well as distribute and ship medications creates multiple ethical concerns. This paper aims to explore two in particular. First, this model creates conflicts of interest for the physicians hired by these companies to write prescriptions. Second, (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  23.  16
    Direct to consumer testing, drugs and gifts.Ruth Chadwick - 2020 - Bioethics 34 (3):222-222.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  24.  16
    Direct-to-consumer advertising.F. J. Haddy - 2010 - The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha 73 (3):38.
    Direct download  
     
    Export citation  
     
    Bookmark  
  25.  41
    Strategic Maneuvering in Direct to Consumer Drug Advertising: A Study in Argumentation Theory and New Institutional Theory.G. Thomas Goodnight - 2008 - Argumentation 22 (3):359-371.
    New Institutional Theory is used to explain the context for argumentation in modern practice. The illustration of Direct to Consumer Drug advertising is deployed to show how communicative argument between a doctor and patient is influenced by force exogenous to the practice of medicine. The essay shows how strategic maneuvering shifts the burden of proof within institutional relations.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  26.  30
    Direct-to-Consumer Neurotechnology: What Is It and What Is It for?Marcello Ienca & Effy Vayena - 2019 - American Journal of Bioethics Neuroscience 10 (4):149-151.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  27.  19
    (1 other version)Informed Consent in Direct-to-Consumer Personal Genome Testing: The Outline of A Model between Specific and Generic Consent.Eline M. Bunnik, A. Cecile J. W. Janssens & Maartje H. N. Schermer - 2012 - Bioethics 28 (7):343-351.
    Broad genome‐wide testing is increasingly finding its way to the public through the online direct‐to‐consumer marketing of so‐called personal genome tests. Personal genome tests estimate genetic susceptibilities to multiple diseases and other phenotypic traits simultaneously. Providers commonly make use of Terms of Service agreements rather than informed consent procedures. However, to protect consumers from the potential physical, psychological and social harms associated with personal genome testing and to promote autonomous decision‐making with regard to the testing offer, we argue (...)
    Direct download  
     
    Export citation  
     
    Bookmark   5 citations  
  28.  40
    Direct-to-consumer genomics on the scales of autonomy.Effy Vayena - 2015 - Journal of Medical Ethics 41 (4):310-314.
  29.  24
    Direct-to-Consumer Neurotechnology: A Grounded Appraisal.Anna Wexler - 2019 - American Journal of Bioethics Neuroscience 10 (4):172-174.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  30.  22
    Ethical Issues Surrounding Direct-to-Consumer Advertising of Neurotechnology.Donna Hanrahan - 2012 - Ethics in Biology, Engineering and Medicine 3 (1-3):173-184.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  31.  98
    Is banning direct to consumer advertising of prescription medicine justified paternalism?Uvonne Lau - 2005 - Journal of Bioethical Inquiry 2 (2):69-74.
    New Zealand is one of two OECD countries in the world where direct-to-consumer advertising of prescription medicine (DTCA-PM) is permitted. Increase in such activity in recent years has resulted in a disproportionate increase in dispensary volume of heavily advertised medicines. Concern for the potential harm to healthcare consumers and the public healthcare system has prompted the medical profession to call for a ban on DTCA-PM as the best way of protecting the public interest. Such blanket prohibition however also (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  32.  21
    The Dangers of Direct-to-Consumer Genetic Testing for Alzheimer’s Disease: Comment on “Personal Genomic Testing, Genetic Inheritance, and Uncertainty”.Paul Lacaze, Jane Tiller & Joanne Ryan - 2017 - Journal of Bioethical Inquiry 14 (4):585-587.
    The overarching issue with this case study is poor regulation and quality control over direct-to-consumer genetic testing, delivered in the absence of any medical oversight.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  33.  33
    Direct-to-Consumer Genomics and Research Ethics: Should a More Robust Informed Consent Process Be Included?Katherine Wasson - 2009 - American Journal of Bioethics 9 (6):56-58.
    An important issue raised in the article by Lee and Crawley (2009) is whether direct-to-consumer (DTC) genomics, specifically personal genome testing (PGT) should be considered research. The author...
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  34.  49
    Dimensions of Ethical Direct-to-Consumer Neurotechnologies.Karola V. Kreitmair - 2019 - American Journal of Bioethics Neuroscience 10 (4):152-166.
    Not too long ago, neurotechnology was the purview of the clinic and research. In 2011, researchers at Brown University succeeded for the first time in using an implanted sensor in the brain of a pa...
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   25 citations  
  35.  28
    Direct-to-Consumer Advertising of Health-Related Goods and Services.Donald Thompson - 2014 - American Journal of Bioethics 14 (3):53-54.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  36.  25
    Direct to consumer genetic testing and the libertarian right to test.Michele Loi - 2016 - Journal of Medical Ethics 42 (9):574-577.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  37.  31
    Direct-to-consumer online genetic testing and the four principles: an analysis of the ethical issues.Katherin Wasson, E. David Cook & K. Helzlsouer - 2005 - Ethics and Medicine 22 (2).
    Direct download  
     
    Export citation  
     
    Bookmark   4 citations  
  38.  40
    Direct-to-Consumer Genome-Wide Scans: Astrologicogenomics or Simple Scams?Wayne Hall & Coral Gartner - 2009 - American Journal of Bioethics 9 (6-7):54-56.
  39.  76
    Ethical considerations in the use of direct-to-consumer advertising and pharmaceutical promotions: The impact on pharmaceutical sales and physicians. [REVIEW]R. Stephen Parker & Charles E. Pettijohn - 2003 - Journal of Business Ethics 48 (3):279-290.
    The influence of direct-to-consumer advertising and physician promotions are examined in this study. We further examine some of the ethical issues which may arise when physicians accept promotional products from pharmaceutical companies. The data revealed that direct-to-consumer advertising is likely to increase the request rates of both the drug category and the drug brand choices, as well as the likelihood that those drugs will be prescribed by physicians. The data further revealed that the majority of responding (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  40.  37
    “I would rather have it done by a doctor”—laypeople’s perceptions of direct-to-consumer genetic testing (DTC GT) and its ethical implications.Manuel Schaper, Sabine Wöhlke & Silke Schicktanz - 2019 - Medicine, Health Care and Philosophy 22 (1):31-40.
    Direct-to-consumer genetic testing has been available for several years now, with varying degrees of regulation across different countries. Despite a restrictive legal framework it is possible for consumers to order genetic tests from companies located in other countries. However, German laypeople’s awareness and perceptions of DTC GT services is still unexplored. We conducted seven focus groups with German laypeople to explore their perceptions of and attitudes towards commercial genetic testing and its ethical implications. Participants were critical towards DTC (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  41.  32
    Medicine, market and communication: ethical considerations in regard to persuasive communication in direct-to-consumer genetic testing services.Manuel Schaper & Silke Schicktanz - 2018 - BMC Medical Ethics 19 (1):1-11.
    Commercial genetic testing offered over the internet, known as direct-to-consumer genetic testing (DTC GT), currently is under ethical attack. A common critique aims at the limited validation of the tests as well as the risk of psycho-social stress or adaption of incorrect behavior by users triggered by misleading health information. Here, we examine in detail the specific role of advertising communication of DTC GT companies from a medical ethical perspective. Our argumentative analysis departs from the starting point that (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  42. Liability implications of direct-to-consumer genetic testing.E. Marchant Gary, Ellen Mark Barnes, Susan W. Clayton & M. Wolf - 2021 - In I. Glenn Cohen, Nita A. Farahany, Henry T. Greely & Carmel Shachar (eds.), Consumer genetic technologies: ethical and legal considerations. New York, NY: Cambridge University Press.
     
    Export citation  
     
    Bookmark  
  43. Privacy best practices for direct-to-consumer genetic testing services : are industry efforts at self-regulation sufficient?James W. Hazel - 2021 - In I. Glenn Cohen, Nita A. Farahany, Henry T. Greely & Carmel Shachar (eds.), Consumer genetic technologies: ethical and legal considerations. New York, NY: Cambridge University Press.
     
    Export citation  
     
    Bookmark  
  44. Losing our minds? direct-to-consumer genetic testing and Alzheimer's disease.Emily Largent - 2021 - In I. Glenn Cohen, Nita A. Farahany, Henry T. Greely & Carmel Shachar (eds.), Consumer genetic technologies: ethical and legal considerations. New York, NY: Cambridge University Press.
  45.  37
    Is banning direct to consumer advertising of prescription medicine justified paternalism?Uvonne Lau General Surgeon - 2005 - Journal of Bioethical Inquiry 2 (2).
    Direct download  
     
    Export citation  
     
    Bookmark  
  46.  29
    My Experience with Direct to Consumer Genetic Testing.Sarah M. Hartz - 2015 - Narrative Inquiry in Bioethics 5 (3):208-210.
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark  
  47.  31
    Developing Measurement Scales of Organizational and Issue Legitimacy: A Case of Direct-to-Consumer Advertising in the Pharmaceutical Industry.Jee Young Chung, Bruce K. Berger & Jamie DeCoster - 2016 - Journal of Business Ethics 137 (2):405-413.
    The purpose of this paper is to explore the concepts of issue legitimacy and organizational legitimacy, providing a new measure of each construct. The scales were developed and tested using data collected through a statewide survey of Alabama residents. Assessments of issue legitimacy were based on perceptions of direct-to-consumer advertising, whereas assessments of organizational legitimacy were based on perceptions of the pharmaceutical industry as a whole. The findings provide evidence that organizational legitimacy can be reliably measured using a (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  48. Privacy, autonomy and direct-to-consumer genetic testing: a response to Vayena.Kyle van Oosterum - 2022 - Journal of Medical Ethics 48 (10):774-775.
    In Vayena’s article, ‘direct-to-consumer (DTC) genomics on the scales of autonomy’, she claims that there may be a strong autonomy-based argument for permitting DTC genomic services. In this response, I point out how the diminishment of one’s genetic privacy can cause a relevant autonomy-related harm which must be balanced against the autonomy-related gains DTC services provide. By drawing on conceptual connections between privacy and the Razian conception of autonomy, I show that DTC genetic testing may decrease the range (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark  
  49.  48
    Nonpropositional Content in Direct-to-Consumer Genetic Testing Advertisements.Pascal Borry, Mahsa Shabani & Heidi Carmen Howard - 2013 - American Journal of Bioethics 13 (5):14-16.
  50.  50
    Research 2.0: Social Networking and Direct-To-Consumer (DTC) Genomics.Sandra Soo-Jin Lee & LaVera Crawley - 2009 - American Journal of Bioethics 9 (6-7):35-44.
    The convergence of increasingly efficient high throughput sequencing technology and ubiquitous Internet use by the public has fueled the proliferation of companies that provide personal genetic information (PGI) direct-to-consumers. Companies such as 23andme (Mountain View, CA) and Navigenics (Foster City, CA) are emblematic of a growing market for PGI that some argue represents a paradigm shift in how the public values this information and incorporates it into how they behave and plan for their futures. This new class of social (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   16 citations  
1 — 50 / 984